CareDx (CDNA) Tops Q2 EPS by 21c

CareDx (NASDAQ: CDNA) reported Q2 EPS of ($0.13), $0.21 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $80.6 million versus the consensus estimate of $81.85 million.

GUIDANCE:

CareDx sees FY2022 revenue of $325-335 million, versus the consensus of $338 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
• UBS Downgrades EasyJet Plc. (EZJ:LN) (ESYJY) to Neutral
• Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance